156 related articles for article (PubMed ID: 9663714)
1. Management of an anti-factor VIII inhibitor occurring during surgical procedure with continuous infusion of Novoseven.
Ménart C; Cognet V; Petit PY; Massignon D; Négrier C
Blood Coagul Fibrinolysis; 1998 Apr; 9(3):289-90. PubMed ID: 9663714
[No Abstract] [Full Text] [Related]
2. Successful use of recombinant factor VIIa for hemostasis during total knee replacement in a severe hemophiliac with high-titer factor VIII inhibitor.
Carr ME; Loughran TP; Cardea JA; Smith WK; Kuhn JG; Dottore MV
Int J Hematol; 2002 Jan; 75(1):95-9. PubMed ID: 11843300
[TBL] [Abstract][Full Text] [Related]
3. Successful use of recombinant factor VIIa in a haemophiliac with inhibitor undergoing cataract surgery.
Biron-Andréani C; Dupeyron G; Mainemer M; Schved JF
Blood Coagul Fibrinolysis; 2001 Apr; 12(3):215-6. PubMed ID: 11414637
[TBL] [Abstract][Full Text] [Related]
4. Failure of recombinant activated factor VII during surgery in a hemophiliac with high-titer factor VIII antibody.
Gringeri A; Santagostino E; Mannucci PM
Haemostasis; 1991; 21(1):1-4. PubMed ID: 1907588
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting choice of hemostatic agent for the hemophilia patient with an inhibitor antibody.
Monahan PE; Aledort LM;
Am J Hematol; 2004 Dec; 77(4):346-50. PubMed ID: 15558804
[TBL] [Abstract][Full Text] [Related]
6. Continuous infusion of recombinant factor VIIa: continue or not?
Ewenstein BM
Thromb Haemost; 2001 Oct; 86(4):942-4. PubMed ID: 11686349
[No Abstract] [Full Text] [Related]
7. Use of recombinant factor VIIa (NovoSeven) in a haemophilia A patient with inhibitor in Kuwait.
Kanyike FB; Abdul-Salam SA; Prakash B; Sharhan A; Wahib N; Youssef AH
Haemophilia; 1999 Jul; 5(4):273-5. PubMed ID: 10469183
[TBL] [Abstract][Full Text] [Related]
8. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
[TBL] [Abstract][Full Text] [Related]
9. Successful total hip replacement in a patient with severe haemophilia A with inhibitors using recombinant factor VIIa.
Pasa S; Altintas A; Cil T; Danis R; Subasi M; Ayyildiz O; Muftuoglu E
Haemophilia; 2008 Jul; 14(4):863-5. PubMed ID: 18445012
[No Abstract] [Full Text] [Related]
10. Recombinant FVIIa (NovoSeven) continuous infusion and total hip replacement in patients with haemophilia and high titre of inhibitors to FVIII: experience of two cases.
Tagariello G; De Biasi E; Gajo GB; Risato R; Radossi P; Davoli PG; Traldi A
Haemophilia; 2000 Sep; 6(5):581-3. PubMed ID: 11012706
[TBL] [Abstract][Full Text] [Related]
11. Approaches to successful total knee arthroplasty in haemophilia A patients with inhibitors.
Konkle BA; Nelson C; Forsyth A; Hume E
Haemophilia; 2002 Sep; 8(5):706-10. PubMed ID: 12199684
[No Abstract] [Full Text] [Related]
12. Recombinant factor VIIa and factor VIII treatment for acquired factor VIII deficiency: a case of repeated thrombotic endotracheal occlusion in a mechanically ventilated patient.
Lauer S; Westphal M; Fischer LG; Meissner A; Van Aken H; Freise H
Crit Care; 2011; 15(2):407. PubMed ID: 21418550
[No Abstract] [Full Text] [Related]
13. Thrombelastography-guided factor VIIa therapy in a surgical patient with severe hemophilia and factor VIII inhibitor.
Pivalizza EG; Escobar MA
Anesth Analg; 2008 Aug; 107(2):398-401. PubMed ID: 18633014
[TBL] [Abstract][Full Text] [Related]
14. Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.
Economou M; Teli A; Tzantzaroudi A; Tsatra I; Zavitsanakis A; Athanassiou-Metaxa M
Haemophilia; 2008 Mar; 14(2):390-1. PubMed ID: 18194305
[No Abstract] [Full Text] [Related]
15. Summary of clinical experience with recombinant factor VIII products--Recombinate.
White GC
Ann Hematol; 1994; 68 Suppl 3():S7-8. PubMed ID: 8180260
[No Abstract] [Full Text] [Related]
16. Experiences with recombinant factor VIIa in haemophiliacs.
Hedner U
Curr Stud Hematol Blood Transfus; 1991; (58):63-8. PubMed ID: 1954776
[No Abstract] [Full Text] [Related]
17. Interdisciplinary management of total knee replacement in a haemophilia patient with high-titre inhibitor and severe arthropathy complicated by an aneurysmatic bone cyst.
Ilg A; Stahlschmidt K; Zotz RB; Krauspe R; Scharf RE; Gerhardt A
Haemophilia; 2009 Jan; 15(1):377-9. PubMed ID: 19149863
[No Abstract] [Full Text] [Related]
18. The use of agents that by-pass factor VIII inhibitors in patients with haemophilia.
Roberts HR
Vox Sang; 1999; 77 Suppl 1():38-41. PubMed ID: 10529686
[No Abstract] [Full Text] [Related]
19. Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleeding.
Smith MP; Ludlam CA; Collins PW; Hay CR; Wilde JT; Grigeri A; Melsen T; Savidge GF
Thromb Haemost; 2001 Oct; 86(4):949-53. PubMed ID: 11686351
[TBL] [Abstract][Full Text] [Related]
20. Treatment of an acquired factor VIII inhibitor with sequential recombinant factor VIIa and FEIBA.
Miranda GG; Rodgers GM
Haemophilia; 2009 Jan; 15(1):383-5. PubMed ID: 18759746
[No Abstract] [Full Text] [Related]
[Next] [New Search]
